Synaptogenix Price to Sales Ratio 2020-2025 | TAOX
Historical PS ratio values for Synaptogenix (TAOX) over the last 10 years. The current P/S ratio for Synaptogenix as of July 04, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Synaptogenix P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-07-02 |
8.08 |
|
0.00 |
| 2025-03-31 |
2.42 |
0 |
0.00 |
| 2024-12-31 |
3.47 |
0 |
0.00 |
| 2024-09-30 |
3.02 |
0 |
0.00 |
| 2024-06-30 |
4.10 |
0 |
0.00 |
| 2024-03-31 |
4.69 |
0 |
0.00 |
| 2023-12-31 |
6.80 |
0 |
0.00 |
| 2023-09-30 |
11.00 |
0 |
0.00 |
| 2023-06-30 |
23.19 |
0 |
0.00 |
| 2023-03-31 |
20.00 |
0 |
0.00 |
| 2022-12-31 |
29.00 |
0 |
0.00 |
| 2022-09-30 |
167.50 |
0 |
0.00 |
| 2022-06-30 |
129.75 |
0 |
0.00 |
| 2022-03-31 |
193.50 |
0 |
0.00 |
| 2021-12-31 |
212.75 |
0 |
0.00 |
| 2021-09-30 |
248.50 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.012B |
$0.000B |
|
Synaptogenix Inc. is an emerging biopharmaceutical company. It focused on developing therapies for neurodegenerative diseases. The company's lead therapeutic candidate consist Bryostatin-1. Synaptogenix Inc. is based in NEW YORK.
|
